and Cookies must be enabled.
Please click here to go directly to online submission
Journal of Neurodegeneration and Regeneration (JNDR) is designed to provide
physicians and researchers with the most current information and breakthroughs
in the field of neurology, including recent developments regarding the
molecular mechanisms of neurodegeneration and neuroprotection, methods of early
detection of neurodegenerative diseases, and potential therapies or cures for
currently untreatable conditions.
Neurodegeneration and Regeneration publishes original research articles,
clinical reports, brief communications, articles related to new ideas or
innovations, letters to the editor, editorials, invited book reviews, and
Cathy M. Helgason, MD
Director of Cerebrovascular Services, Department of
University of Illinois, College of Medicine at Chicago
||Philippe Taupin, PhD
Vision Research Institute
National Institute for Cellular
Dublin City University
Journal of Neurodegeneration and
470 Boston Post Road
Weston, MA 02493
Phone (781) 899
Fax (781) 899 - 4900
Monday through Friday 8:30 am - 5 pm
for consideration must not have been previously published (except as an
abstract) and must not be under consideration for publication elsewhere.
JNDR encourages the online submission of materials to be considered for
publication. Online submission (with instructions) is available at
Those without access to online
submission may submit manuscripts to the Editor. Manuscripts submitted by mail
must include one hard copy and a copy on computer disk. Each mailed submission
must include one full set of original figures as well as figures on diskette or
CD if possible. Manuscripts submitted by mail will be uploaded to the online
system in the JNDR editorial office.
Submission of a manuscript to JNDR is taken as evidence that no portion of
the text or figures has been published or submitted for publication elsewhere
unless information regarding previous publication is explicitly cited and
copyright permission obtained (fax or mail to JNDR editorial office - see
above) at the time of manuscript submission. Permission should be obtained for
both print and online publication.
Two independent peer
reviews are typically solicited. At the discretion of the Managing Editor, a
third review may also be solicited. The Editor is responsible for all final
decisions regarding acceptance or rejection, recommendations for revision, and
Publication of material in JNDR should not be
interpreted as an endorsement of the material contained therein. The publisher
will send galley proofs of accepted manuscripts (pdf file) to the corresponding
author via e-mail. Corrections and revisions should be returned to the
publisher via e-mail as instructed. Authors are responsible for the accuracy of
references and statistical computations. The author(s) acknowledge that the
publisher reserves the right to charge authors for excessive revisions made to
their galley proofs. Authors are responsible for all excessive revision charges
associated with their article. Publication may be withheld if authors fail to
fulfill these financial obligations.
Single reprints may be purchased online at www.neuroregen.com; click on the
"Abstracts" link and select year of publication to view all abstracts and
purchase your selection. Reprints in quantities of 100 or more may be ordered
from JNDR, 470 Boston Post Road, Weston, MA 02493; telephone: (781) 899-2702;
fax: (781) 899-4900.
All authors must sign
the JNDR copyright transfer form. This form will be sent to you when the
article has been accepted . The signed form must be received by mail or fax at
the JNDR editorial office before an accepted manuscript can be forwarded for
The corresponding author is responsible
for ensuring that all individuals named as co-authors have made a major
contribution to the manuscript. Authorship credit should be based on
significant contributions to all of the following: 1) conception and design, or
acquisition of data, or analysis and interpretation of data; 2) drafting of the
manuscript or critical revision of the manuscript for important intellectual
content; and 3) final approval of submitted manuscript. Each author must
declare his or her contribution to the manuscript on the copyright transfer
form from the JNDR editorial office.
Financial Disclosure/Conflict of
Authors are required to
disclose, in a cover letter accompanying their manuscript, any relevant
conflict of interest, including direct or indirect financial interests they may
have in the materials or subject matter dealt with in the manuscript. This
information will be held in confidence by the Editor during the review process
but, at the discretion of the Editor, may be included in publication of an
JNDR allows research groups to be recognized
in submitted manuscripts. Two options are available.
1. The names of
individuals appear in the byline designated as writing for the research group
(e.g., Smith A, Johnson R, Williams T; for the CleftCran Research Group). The
named individuals must meet the full criteria and requirements for authorship
as described in the previous section. Other group members who do not qualify
for authorship may be listed in an Acknowledgment.
2. Only the name of the
research group appears in the byline, with an asterisk indicating that the list
of authors qualifying for authorship appears at the end of the article (e.g.,
The CleftCran Research Group*). Again, other group members who do not qualify
for authorship may be listed in the Acknowledgment.
The author is responsible for ensuring the
protection of a patient's anonymity. A signed consent form must accompany any
figure including recognizable individuals. Shading of the eyes is not an
acceptable means of rendering an individual unrecognizable. If an author
chooses to use his/her own institutional patient permission form, it must
include permission to use photographs for all types of publication including
but not limited to print, visual, electronic, or broadcast media. Consent forms
should be mailed or faxed to the JNDR editorial office.
Animals in Research
For manuscripts describing the
results of experimental studies on humans, the authors must provide a statement
in the Methods section of the manuscript that an institutional review board
(IRB) approved the study and that informed consent was obtained. If a formal
IRB is not available, the authors must include a statement in the manuscript
that principles outlined in the Declaration of Helsinki were followed.
Information regarding the Declaration of Helsinki may be found at
Original Articles: Reports of
original clinical or basic science data pertaining to prevalence, causes,
mechanisms, diagnosis, course, treatment, and prevention, including systematic
reviews and meta-analysis that represent a new contribution to the field.
Clinical Reports: Case reports presenting new or novel clinical
Ideas and Innovations: Short communications related
to novel ideas, techniques, methods of assessment, etc.
Communications: Preliminary or limited results (fewer than 1500 words, up
to three figures or tables) of original research pertaining to prevalence,
causes, mechanisms, diagnosis, course, treatment, and prevention.
Letters to the Editor: Comments in the form of letters that express
differences of opinion or supporting views of recently published JNDR
Editorials: Brief substantiated commentaries (fewer than
1000 words) on subjects of interest to the JNDR readership. Editorials should
be narrative in form.
The American Medical
Association Manual of Style is the standard reference for manuscript style.
Manuscripts should be typed, double-spaced with 1" margins, and left justified.
Use a standard 12-point font. Pages should be numbered consecutively in the
upper right-hand corner. Do not print a running title. Turn off your word
processing program's hyphenation feature and "smart quotes" feature before
typing. Headings must be used to designate the major divisions of the
manuscript. Up to three levels of headings may be used.
Page one must include:
- Title (maximum 20 words)
- Author names with degrees, in the order that they will appear
- Academic rank or position and institutional affiliation for
- Name, address, telephone number, fax number, and e-mail address
of the corresponding author who will receive editorial correspondence and
- If applicable, statement that paper was presented orally at a
professional meeting, including the name, date, and location of the
- Credits and appropriate grant numbers if the study was
supported by an agency
- Running title (eight words or less)
Original articles and ideas and innovations articles should include a
structured abstract of no longer than 250 words with the following headings and
information, as applicable. Clinical reports should include an unstructured
abstract of no longer than 100 words describing the objective, essential
features and uniqueness of the case being presented, and conclusions.
Structured abstracts of no longer than 150 words should be used for data-based
Brief Communications articles. Non-data-based Brief Communications should
include an unstructured abstract of no longer than 100 words.
Objective: State the main question or objective
of the study and the major hypothesis tested, if any.
Describe the design of the study indicating, as appropriate, use of
randomization, blinding, criterion standards for diagnostic tests, temporal
direction (retrospective or prospective), etc.
the study setting, including the level of clinical care (for example, primary
or tertiary, private practice or institutional).
Participants: State selection procedures, entry criteria, and numbers of
participants entering and finishing the study.
Describe the essential features of any intervention, including the methods and
duration of administration.
Main Outcome Measure(s): The primary
study outcome measures should be indicated as planned before data collection
began. If the hypothesis being reported was formulated during or after data
collection, this fact should be clearly stated.
measurements that are not evident from the nature of the main results and
indicate any blinding. If possible, the results should be accompanied by
confidence intervals (most often the 95 percent interval) and the exact level
of statistical significance. For comparative studies, confidence intervals
should relate to the differences between groups. Absolute values should be
indicated when risk changes or effect sizes are given.
Conclusions: State only those conclusions of the study that are
directly supported by data, along with their clinical application (avoiding
overgeneralization) and/or whether additional study is required before the
information should be used in clinical settings. Equal emphasis must be given
to positive and negative findings of equal scientific merit.
Words: A short list of key words that reflects the article's content
should follow the abstract.
(Reproduced with permission from:
Haynes RB et al.: More informative abstracts revisited. Ann Intern Med.
1990; 113: 69-76).
If a statistical analysis is conducted, explanation of the methods used must
precede the Results section in the manuscript. Unusual or complex analysis
methods should be referenced.
Tables should be numbered consecutively using Arabic numerals. Each table
should have an appropriate title and explanation at its head. Tables may be
submitted as part of the manuscript document file, with each table placed on a
separate page following the references. Alternatively, tables may be submitted
electronically as separate files, with one table per file, in either .doc
(text) or .xls (spreadsheet) format.
All figures and illustrations must be original photographs or artwork. Figures
should be numbered consecutively in the order in which they appear in the
manuscript, using Arabic numerals. A list of figure legends must be included on
a separate page following the body of the manuscript. The legend should explain
each figure in detail.
Figures should be
submitted in one of the following formats: tif, eps, jpg, pdf. Each figure
should be submitted as a separate file. Composite figures made up of more than
one image should be submitted as separate files (e.g., Fig 1A, Fig
Color (CMYK) or
grayscale images containing only pictures (no text or thin lines) should be
scanned at a resolution of 300 dpi and an image width of at least 3.25". Color
(CMYK) or grayscale images containing a combination of pictures and text or
thin lines should be scanned at 600 dpi and an image width of at least 3.25".
Monochrome (black and white) images such as line art or line graphs should be
scanned at a resolution of 1200 dpi. For symbols that must be explained, please
use a key that can be shot with the figures. Do not explain them using symbols
in the figure legend. Authors may be charged if artwork has to be generated to
incorporate figure symbols into the figure legend.
at lower than the required resolutions stated above will be allowed for review
purposes. However, the publication process for accepted manuscripts will be
delayed until acceptable images have been submitted.
The metric system is preferred for
expressing units of measure. Abbreviations may be used for terms. Write out the
full term for each abbreviation at its first use in the text, unless the
abbreviation is a standard unit of measure. Abbreviations used in a table must
be explained in a footnote below the table. For a list of standard
abbreviations, consult the Council of Biology Editors Style Guide (available
from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814)
or other standard sources.
Acknowledge all forms of financial support on the title page. List all
other acknowledgments in a paragraph at the end of the manuscript.
References are organized in AMA format; that is, they are to be cited
numerically in the text and in consecutive order, including the first three
authors followed by et al., and listed at the end of the article in the
1. Mudd P, Smith JG, Allen AZ, et al.: High ideals and hard cases: The
evolution of opioid therapy for cancer pain. Hastings Cent Rep. 1982;
Books 1. Bayles SP
(ed.): Nutritional Supplements and Interactions with Analgesics. Boston:
GK Hall & Co., 1978.
Book chapters 1.
Martin RJ, Post SG: Introducing alternative prescribing strategies. In Smith J,
Howard RP, Donaldson P (eds.): The Oncology Management Handbook.
Madison, WI: Clearwater Press, 1998, pp. 310-334.
Web sites Health
Care Financing Administration: HCFA Statistics at a glance. Available at:
www.hcfa/gov/stats/stahili.htm. Accessed December 27, 2002.
submission process starts by pressing the "Submit Manuscript" link on your
HOME to continue.
||(For PC users)
||(For Mac users)